Zacks Investment ResearchMon, 22 Jun 2026 15:31:24 GMTQURE Announces Initial Data on Gene therapy for Temporal Lobe EpilepsyQURE-0.09%
Zacks Investment ResearchFri, 19 Jun 2026 19:20:32 GMTQURE Soars as FDA Backs AMT-130 Data for Accelerated ApprovalQURE-0.09%
Seeking AlphaThu, 18 Jun 2026 14:06:55 GMTUniQure: AMT-130's FDA Path Reaffirms My Bull CaseQURE-0.09%
Zacks Investment ResearchThu, 18 Jun 2026 12:31:06 GMTuniQure (QURE) Soars 78.4%: Is Further Upside Left in the Stock?QURE-0.09%
Seeking AlphaWed, 17 Jun 2026 19:40:38 GMTuniQure: FDA's Latest Stance On Huntington's BLA Sends Stock SoaringQURE-0.09%
Investors Business DailyWed, 17 Jun 2026 18:12:06 GMTBiotech Stocks Surge As UniQure 'Nail-Biting Journey' Comes To An EndQURE-0.09%
CNBCWed, 17 Jun 2026 16:12:05 GMTUniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agencyQURE-0.09%
BenzingaWed, 17 Jun 2026 14:31:44 GMTFDA Signals uniQure Huntington Gene Therapy Data Could Back Accelerated ApprovalQURE-0.09%
BarronsWed, 17 Jun 2026 14:10:00 GMTThis Biotech Stock Is Surging 66% on Surprise Good News From FDAQURE-0.09%
Seeking AlphaMon, 01 Jun 2026 15:14:55 GMTuniQure: Why A Shifting FDA Could Change Everything For AMT-130QURE-0.09%
Seeking AlphaTue, 12 May 2026 14:24:05 GMTUniQure Q1 Earnings Review: Limited Progress With FDA, But UK Approval In PlayQURE-0.09%
Seeking AlphaTue, 05 May 2026 19:41:26 GMTuniQure N.V. (QURE) Q1 2026 Earnings Call TranscriptQURE-0.09%
Zacks Investment ResearchTue, 05 May 2026 13:26:11 GMTuniQure (QURE) Reports Q1 Loss, Misses Revenue EstimatesQURE-0.09%
